Literature DB >> 16694241

THE EFFECTS ON RENAL ACTIVITY OF THE ORAL ADMINISTRATION OF PHLORIZIN IN MAN.

W Goldring1, C Welsh.   

Abstract

Entities:  

Year:  1934        PMID： 16694241      PMCID： PMC436026          DOI： 10.1172/JCI100618

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  1 in total

1.  THE ACTION OF PHLORIZIN ON THE EXCRETION OF GLUCOSE, XYLOSE, SUCROSE, CREATININE AND UREA BY MAN.

Authors:  H Chasis; N Jolliffe; H W Smith
Journal:  J Clin Invest       Date:  1933-11       Impact factor: 14.808
  1 in total
  3 in total

1.  THE RENAL EXCRETION OF CREATININE IN MAN.

Authors:  J A Shannon
Journal:  J Clin Invest       Date:  1935-07       Impact factor: 14.808

2.  LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.

Authors:  B Zambrowicz; J Freiman; P M Brown; K S Frazier; A Turnage; J Bronner; D Ruff; M Shadoan; P Banks; F Mseeh; D B Rawlins; N C Goodwin; R Mabon; B A Harrison; A Wilson; A Sands; D R Powell
Journal:  Clin Pharmacol Ther       Date:  2012-07-04       Impact factor: 6.875

Review 3.  Sodium-Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research.

Authors:  Amber L Beitelshees; Bruce R Leslie; Simeon I Taylor
Journal:  Diabetes       Date:  2019-06       Impact factor: 9.461
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.